Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.1.01816
European Journal of Endocrinology, Vol 152, Issue 1, 39-45
Copyright © 2005 by European Society of Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jorde, R
Right arrow Articles by Sundsfjord, J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jorde, R
Right arrow Articles by Sundsfjord, J

CLINICAL STUDY

Serum parathyroid hormone (PTH) levels in smokers and non-smokers. The fifth Tromsø study

R Jorde, F Saleh1, Y Figenschau2, E Kamycheva1, E Haug3 and J Sundsfjord2

Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway, 1 Department of Internal Medicine, University Hospital of North Norway, Tromsø, Norway, 2 Department of Clinical Chemistry, University Hospital of North Norway, Tromsø, Norway and 3 Hormone Laboratory, Aker University Hospital, Oslo, Norway

(Correspondence should be addressed to Rolf Jorde, Medical Department B, University Hospital of North Norway, 9038 Tromsø, Norway; Email: rolf.jorde{at}unn.no)

Objective: Smoking is associated with reduced bone density and calcium absorption, and reduced serum levels of vitamin D. A compensatory increase in serum parathyroid hormone (PTH) would therefore be expected as a result of an altered calcium balance. However, reports on PTH levels in smokers are conflicting. As serum PTH levels give important information on the calcium balance, the PTH levels in smokers are of interest.

Subjects and methods: In the fifth Tromsø study, smoking status was recorded and serum PTH measured in 7896 subjects. Intakes of calcium and vitamin D were evaluated with a food-frequency questionnaire. In a follow-up study on 205 subjects, serum 25-hydroxyvitamin D, calcium absorption, and renal excretion of calcium were measured in addition.

Results: The serum PTH levels were significantly lower in smokers than non-smokers (3.1±1.4 vs 3.6±1.9 pmol/l in males; 3.1±1.5 vs 3.6±1.8 pmol/l in females (P < 0.001) after correcting for confounding variables, linear regression). In the smokers, there was no association between number of cigarettes smoked and serum PTH. One year after quitting smoking, serum PTH levels were similar to those of people who had never smoked. The smokers had significantly lower intake of vitamin D, lower serum levels of 25-hydroxyvitamin D and lower calcium absorption. The intake of calcium and the renal excretion of calcium were similar to that in non-smokers.

Conclusions: Smokers have lower serum PTH levels than non-smokers. This cannot be explained by the predictors of serum PTH measured in our study.




This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
M. Sneve, N. Emaus, R. M. Joakimsen, and R. Jorde
The association between serum parathyroid hormone and bone mineral density, and the impact of smoking: the Tromso Study
Eur. J. Endocrinol., March 1, 2008; 158(3): 401 - 409.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. L. Neuhouser, M. J. Barnett, A. R. Kristal, C. B. Ambrosone, I. King, M. Thornquist, and G. Goodman
(n-6) PUFA Increase and Dairy Foods Decrease Prostate Cancer Risk in Heavy Smokers
J. Nutr., July 1, 2007; 137(7): 1821 - 1827.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 European Society of Endocrinology.